MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ:MIRA
US Market

MIRA Pharmaceuticals, Inc. (MIRA) Income Statement

85 Followers

MIRA Pharmaceuticals, Inc. Income Statement

Last quarter (Q ), MIRA Pharmaceuticals, Inc.'s total revenue was $―, a decrease of ― from the same quarter last year. In Q, MIRA Pharmaceuticals, Inc.'s net income was $-1.72M. See MIRA Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22
Total Revenue
---
Cost of Revenue
---
Gross Profit
---
Operating Expense
$ 3.70M$ 8.53M$ 7.05M
Operating Income
$ -3.70M$ -7.62M$ -7.05M
Net Non Operating Interest Income Expense
$ -674.86K$ -3.46M$ -10.25K
Other Income Expense
---
Pretax Income
$ -4.38M$ -11.08M$ -7.06M
Tax Provision
-$ -1.83M-
Earnings From Equity Interest Net Of Tax
---
Net Income Common Stockholders
$ -7.91M$ -11.98M$ -7.06M
Basic EPS
$ -0.57$ -0.64$ -0.48
Diluted EPS
$ -0.57$ -0.64$ -0.48
Basic Average Shares
$ 61.41M$ 18.57M$ 14.75M
Diluted Average Shares
$ 61.41M$ 18.57M$ 14.75M
Dividend Per Share
---
Total Operating Income As Reported
---
Reported Normalized Basic E P S
---
Reported Normalized Diluted E P S
---
Rent Expense Supplemental
---
Total Expenses
$ 3.70M$ 8.53M$ 7.05M
Net Income From Continuing And Discontinued Operation
$ -7.91M$ -11.98M$ -7.06M
Normalized Income
$ -2.83M$ -12.90M-
Interest Expense
---
EBIT
$ -1.39M$ -9.45M-
EBITDA
$ -1.39M$ -8.72M-
Currency in USD

MIRA Pharmaceuticals, Inc. Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis